Subhechcha Ganguly 
In an era where venture capital is often reduced to valuations and exits, Dr. Anand Govindaluri stands apart as a rare blend of scientist, investor, mentor, and nation-builder. A Singapore-based venture capitalist born in Kakinada, Andhra Pradesh, Dr. Anand’s journey is not merely about wealth creation—it is about impact, purpose, and profit, in that order. He considers his meeti ng with the Late Dr APJ Abdul Kalam as transformative who inspired him to focus on innovation as strength for a nation. Dr Anand is also a recipient of the prestigious Dr Kalam Award for promoting Innovation and Entrepreneurship.
Dr. Anand began his professional life as a molecular biologist and biotechnologist, deeply immersed in scientific research. While pursuing his research at the prestigious AIIMS & JNU, New Delhi, an extraordinary opportunity came his way in 1997. He was selected to receive the prestigious Overseas Post-Graduate Research Scholarship at the prestigious National University of Singapore. At the same time, opportunities in the United States were also open to him. Nevertheless, his selection of Singapore was guided by strategic foresight rather than mere convenience.
He describes Singapore as beautiful, innovative, and policy-driven, a nation where clarity of governance enables innovation to flourish. Having lived in Singapore since 1997, Dr. Anand has witnessed its transformation firsthand—from a labour-based economy to a knowledge-driven global hub.
Learning the Craft of Investing
Dr. Anand’s transition from science to finance took shape when he joined Temasek Holdings in 2001, working in its Life Sciences investment division until 2009. Those eight years were formative. Under the guidance of seasoned mentors and through rigorous on-the-job exposure, he learned the art and discipline of investing—risk evaluation, long-term capital deployment, governance, and value creation.
In 2009, he joined Exploit Technologies, the commercialization arm of A*STAR (Agency for Science, Technology and Research), Singapore’s apex R&D body. Rising to the position of Senior Vice President, he led Incubation and spin-up management, mastering the complex process of converting deep research into scalable commercial ventures. For three years, he worked at the intersection of science, entrepreneurship, and policy—an experience that prepared him for the leap that followed.
The Leap of Faith: Govin Capital, Singapore
Leaving behind a secure and well-paid institutional career, Dr. Anand embraced entrepreneurship—fully aware of the risks. In 2014, he founded Govin Capital (https://www.govincapital.com), a Singapore-headquartered venture capital firm focused on early-stage investments in digital health, EdTech, biotech, pharma, medtech, AI, IoT, and allied technologies.
Today, Govin Capital has led and participated in deep-tech investments in digital health, AI & edtech operating across Singapore, India, and the United States. More importantly, the firm is known for deep mentorship, incubation, and strategic value-add, especially in science-led deep-tech sectors.
Dr. Anand’s life mantra is simple yet demanding:
“Take calculated risks—with guidance and mentorship—and execute ruthlessly.”
GOVIN Values:
Govin Capital is guided by a value system captured in the acronym GOVINN:
G – Go Give, Go Win: Sharing knowledge is essential for excellence in business.
O – Outperform, Outreach, Outlast, inspired by Age Quod Agis—do well in whatever you do.
V – Value Creation, both economic and societal.
I – Innovate, core to Govin’s 3i model: Innovate, Incubate, Invest.
N – Nurture, building scalable and sustainable models, particularly in healthcare and education.
This philosophy reflects Dr. Anand’s belief that capital must be patient, principled, and purposeful.
India, Global Economy, and Geopolitics
Dr. Anand believes the world is at a critical economic inflection point. Rising economic nationalism, particularly through high trade tariffs and protectionist policies, could impede global progress—hurting smaller economies more than larger ones.
India, however, stands resilient. While short-term disruptions are inevitable, India’s large consumption base, demographic strength, and strategic geopolitics position it for long-term growth.
Recalling an inspiring conversation with the late Mr. Ratan Tata, Dr. Anand shares a powerful insight:
“The single biggest risk in business is nationalism in business—because it closes economies.”
On the India–EU Free Trade Agreement, he notes that EU nations dominate global innovation rankings. With India’s strong leadership and calibrated diplomacy, he believes the FTA will significantly accelerate India’s innovation and manufacturing ecosystem.
India–Singapore: A Strategic Partnership
For Dr. Anand, the India–Singapore relationship is one of trust and continuity. Singapore—derived from a Sanskrit word—has been among India’s largest FDI partners, with cooperation spanning smart cities, maritime, biotechnology, healthcare, sports, and education.
The Comprehensive Economic Cooperation Agreement (CECA) signed in 2005 removed double taxation and trade barriers, laying the foundation for long-term collaboration. Dr. Anand is confident this partnership will thrive for decades.
Focused Investments in India
His India investments reflect his philosophy of impact-led capital:
Kare4U Healthcare, operating in Bhubaneswar focused on accessible healthcare
Startup Accelerator India, Andhra Pradesh’s 1st healthcare and deep-tech incubator cum venture accelerator
3F Advanced Technologies, a Visakhapatnam-based data analytics company
RayIOT, Bangalore-based medtech startup working on sleep monitoring for newborns and the elderly
For Dr. Anand, a venture is investment-worthy only when impact, purpose, and profit align.
CSR: Quiet, Personal, and Purposeful
Beyond business, Dr. Anand’s CSR engagement is deeply personal. He supports initiatives in nutritious food distribution, education, women empowerment, and literacy. In Singapore, he has contributed to cancer clinics and youth literacy programmes, reflecting his belief that success carries a moral responsibility.
Having attended the Utkarsh Odisha Conclave, Dr. Anand is optimistic about Odisha’s future, seeing strong opportunities across manufacturing, marine biotechnology, spiritual tourism and healthcare
As India makes decisive strides in AI, Quantum Computing, biotechnology, and large-scale manufacturing, Dr. Anand firmly believes that the next decade belongs to India—not just as an economy, but as a global innovation power.
Author:
Dr Anand has recently published a book, The Investors DNA: Impacting Biomedical Startups via Venture Capital. The book is a reflection of his journey from the world of basic science to the business of science as a venture capitalist supporting several companies in healthcare, medtech, biotech and deep-tech.
